Cargando…

Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer

BACKGROUND: Limited evidence suggests that inherited predisposing risk variants might affect the disease outcome. In this study, we analyzed the effect of genome-wide association studies—identified breast cancer-risk single nucleotide polymorphisms on survival of early-stage breast cancer patients i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Fangmeng, Guo, Wenhui, Lin, Yuxiang, Zeng, Bangwei, Qiu, Wei, Huang, Meng, Wang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167771/ https://www.ncbi.nlm.nih.gov/pubmed/30285756 http://dx.doi.org/10.1186/s12967-018-1634-0

Ejemplares similares

The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer
por: Lian, Weibin, et al.
Publicado: (2017)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

Polymorphisms of long non-coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yu, Liuwen, et al.
Publicado: (2020)

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort study
por: Lian, Weibin, et al.
Publicado: (2020)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022)

Associations of Two Common Genetic Variants with Breast Cancer Risk in a Chinese Population: A Stratified Interaction Analysis
por: Lin, Yuxiang, et al.
Publicado: (2014)

Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancer
por: Zhang, Jiantang, et al.
Publicado: (2017)

Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
por: Zhang, Wenzhe, et al.
Publicado: (2023)

The precision relationships between eight GWAS-identified genetic variants and breast cancer in a Chinese population
por: Chen, Yazhen, et al.
Publicado: (2016)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer
por: Li, Yan, et al.
Publicado: (2020)

HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
por: van Uden, D. J. P., et al.
Publicado: (2019)

Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients
por: Li, Yan, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
por: Wang, Chuan, et al.
Publicado: (2013)

Genetic and lifestyle factors for breast cancer risk assessment in Southeast China
por: Zou, Shuqing, et al.
Publicado: (2023)

Patterns of Recurrence after Breast-Conserving Treatment for Early Stage Breast Cancer by Molecular Subtype
por: Noh, Jae Myoung, et al.
Publicado: (2011)

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer
por: Xi, Gangqin, et al.
Publicado: (2021)

Common germline polymorphisms associated with breast cancer-specific survival
por: Pirie, Ailith, et al.
Publicado: (2015)

Unexpected features of breast cancer subtype
por: Liu, Ye-huan, et al.
Publicado: (2015)

Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis
por: Wu, San-Gang, et al.
Publicado: (2017)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial
por: Goussia, Anna, et al.
Publicado: (2018)

Racial disparities in histological subtype, stage, tumor grade and cancer-specific survival in lung cancer
por: Zeng, Hui, et al.
Publicado: (2022)

The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer
por: Ordu, Cetin, et al.
Publicado: (2016)

Breast cancer subtypes and survival in patients with brain metastases
por: Nam, Byung-Ho, et al.
Publicado: (2008)

The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
por: Yu, Xingxing, et al.
Publicado: (2023)

Tumor Subtype-Specific Associations of Hormone-Related Reproductive Factors on Breast Cancer Survival
por: Song, Nan, et al.
Publicado: (2015)

Healthcare use and costs in early breast cancer: a patient-level data analysis according to stage and breast cancer subtype
por: Brandão, Mariana, et al.
Publicado: (2020)

Identifying Two Common Types of Breast Benign Diseases Based on Multiphoton Microscopy
por: Wu, Yan, et al.
Publicado: (2018)

Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis
por: Liu, Rui, et al.
Publicado: (2022)

Disparities in stage at diagnosis among breast cancer molecular subtypes in China
por: Zeng, Hongmei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7jhi8pleo04utkabakpb2kou2r